Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence
Mühlfellner, G.; Mühlfellner, O.; Kaffarnik, H.
Medizinische Klinik 71(18): 775-778
1976
ISSN/ISBN: 0025-8458 PMID: 178987 Document Number: 96969
To 9 patients with hyperlipoproteinemia type II and treated with different hypolipidemic drugs without success, sitosterol was given for a period of 4 to 16 months. The effective dose was 10.56 to 21.12g beta-sitosterol corresponding to 12 to 24g granulate. One patient developed a serious diarrhoe and dropped out. 4 patients showed an impressive decrease of serum cholesterol levels.
Document emailed within 1 workday
Related Documents
Klein, H.H.; Schwarck, H.; Rauschning, W.; Kreuzer, H. 1984: Effect of nisoldipine on electrophysiological parameters in patients pretreated with beta-blockers Arzneimittel-Forschung 34(9): 1035-1037Kessler, W.; Ewers, R.; Krekeler, G. 1979: The complication rate of pretreated and not pretreated patients with hemodialysis, kidney transplantation and radiation therapy Deutsche Zahnarztliche Zeitschrift 34(3): 266-268
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Zöllner, N.; Schmidt-Garve, H.J.; Wolfram, G. 1971: Treatment of hypercholesteremia with beta-pyridylcarbinol. 3. Results of a 5-year supportive therapy Medizinische Klinik 66(13): 474-484
Djukić, V.; Maksimović, Z.; Radak, D.; Pesko, P.; Spika, I. 1984: Risk factors in unsuccessfully treated patients with chronic peripheral arterial insufficiency Srpski Arhiv Za Celokupno Lekarstvo 112(11-12): 1167-1174
Datsenko, Z.M.; Kholodova, I.D.; Kokunin, V.A.; Klimashevskiĭ, V.M.; Peredereĭ, O.F. 1984: Effect of beta-sitosterol incorporated into liposomes on several indicators of lipid metabolism in experimental hypercholesteremia in rats Voprosy Meditsinskoi Khimii 30(6): 33-38
Anjum, F.; Shakoori, A.R. 1994: Sublethal effects of inorganic mercury on the body growth rate and liver function enzymes of phenobarbitone-pretreated and promethazine-pretreated rabbits Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 13(2): 125-132
Ritter, M.M.; Sönnichsen, A.C.; Möhrle, W.; Richter, W.O.; Schwandt, P. 1991: Beta-endorphin plasma levels and their dependence on gender during an enteral glucose load in lean subjects as well as in obese patients before and after weight reduction International Journal of Obesity 15(6): 421-427
Neu, H.C.; Chin, N.X. 1985: A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 4(1): 63-70
Audet, R.; Rioux, F.; Drapeau, G.; Marceau, F. 1997: Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide Journal of Pharmacology and Experimental Therapeutics 280(1): 6-15
Milne, D.B.; Botnen, J. 1986: Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography Clinical Chemistry 32(5): 874-876
Runne, U.; Martin, H. 1986: Changes in telogen rate, hair density, hair diameter and rate of growth in androgenetic alopecia of the male. Simultaneously a contribution to the significance of dysplastic hair Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 37(4): 198-204
Watanabe, Y.; Nunoi, K.; Maki, Y.; Nakamura, Y.; Fujishima, M. 1987: Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria Clinical Nephrology 28(5): 227-231
Rohdewald, P.; Neddermann, E. 1988: Dose-dependence of the analgesic action of metamizol Der Anaesthesist 37(3): 150-155
Bjornsson, T.D.; Levy, G. 1979: Pharmacokinetics of heparin. I. Studies of dose dependence in rats Journal of Pharmacology and Experimental Therapeutics 210(2): 237-242
Murasaki, M. 1996: Clinical dose dependence of anti-anxiety agents Seishin Shinkeigaku Zasshi 98(9): 612-621
Masri, M.; Naiem, M.; Daar, A.S. 1987: Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice Transplantation Proceedings 19(1 Part 2): 1212-1213
Grossklaus, R. 1987: Dose dependence of the energy utilization of sugar substitutes Deutsche Zahnarztliche Zeitschrift 42(10 Suppl 1: S154-S158
Vrdoljak, E.; Omrcen, T.; Boban, M.; Hrepic, D. 2008: Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients Journal of BUON: Official Journal of the Balkan Union of Oncology 13(4): 513-518
Weber, G.; Bertelli, E.; Lungarella, G.; Bianciardi, G. 1976: Studies with the freeze etching method on circulating blood platelets in patients with dyslipemia and in experimental hypercholesteremia. Preliminary note Archivio "de Vecchi" Per l'Anatomia Patologica E la Medicina Clinica 61(1): 69-75